A skin cancer drug may rapidly reverse pathological, cognitive and memory deterioration associated with Alzheimer’s disease, according to new research published on Thursday.

Bexarotene, a drug that is currently used to combat T cell lymphoma, appeared to reverse plaque buildup and improve memory in the brains of mice with Alzheimer’s disease by reducing levels of beta-amyloid plaques in the brain that cause mental deficits in Alzheimer’s disease.
Inside the living brain of a mouse model of Alzheimer’s disease

Researchers said the findings were particularly promising because the drug worked with “unprecedented speed” by reducing soluble amyloid by 25 percent and its buildup in the brain by 50 percent in three days.

combat T cell